Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026)
Zimmer Biomet Holdings (ZBH) posted quarterly Total Non-Current Liabilities of $9.4 billion for Q1 2026, down 2.42% year-over-year from $9.6 billion in Q1 2025, and down 3.59% quarter-over-quarter from $9.8 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Total Non-Current Liabilities history runs 18 years deep, the most recent figure standing at $9.4 billion for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 2.42% year-over-year to $9.4 billion; the TTM figure through Mar 2026 stood at $9.4 billion (down 2.42% YoY), while the FY2025 annual figure was $9.8 billion, up 12.07% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $9.4 billion, down from $9.8 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $9.9 billion in Q3 2025, with the low at $7.6 billion in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $8.6 billion (2024), against an average of $8.8 billion.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities fell 20.99% in 2022, then increased 24.94% in 2025.
- Zimmer Biomet Holdings' Total Non-Current Liabilities stood at $8.4 billion in 2022, then dropped by 3.85% to $8.1 billion in 2023, then climbed by 7.74% to $8.7 billion in 2024, then climbed by 12.07% to $9.8 billion in 2025, then dropped by 3.59% to $9.4 billion in 2026.
- Business Quant data shows ZBH's Total Non-Current Liabilities at $9.4 billion in Q1 2026, $9.8 billion in Q4 2025, and $9.9 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.53 Bn |
| Mar 31, 2026 | 9.41 Bn |
| Dec 31, 2025 | 9.76 Bn |
| Sep 30, 2025 | 9.92 Bn |
| Jun 30, 2025 | 9.45 Bn |
| Mar 31, 2025 | 9.64 Bn |
| Dec 31, 2024 | 8.71 Bn |
| Sep 30, 2024 | 8.31 Bn |
| Jun 30, 2024 | 7.57 Bn |
| Mar 31, 2024 | 8.57 Bn |
| Dec 31, 2023 | 8.08 Bn |
| Sep 30, 2023 | 8.30 Bn |
| Jun 30, 2023 | 8.27 Bn |
| Mar 31, 2023 | 8.45 Bn |
| Dec 31, 2022 | 8.41 Bn |
| Sep 30, 2022 | 8.47 Bn |
| Jun 30, 2022 | 8.74 Bn |
| Mar 31, 2022 | 9.04 Bn |
| Dec 31, 2021 | 10.24 Bn |
| Sep 30, 2021 | 10.70 Bn |